Jointown Pharmaceutical Group Statistics

Total Valuation

Jointown Pharmaceutical Group has a market cap or net worth of CNY 24.36 billion. The enterprise value is 30.59 billion.

Market Cap	24.36B
Enterprise Value	30.59B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Jointown Pharmaceutical Group has 4.91 billion shares outstanding. The number of shares has decreased by -2.09% in one year.

Current Share Class	n/a
Shares Outstanding	4.91B
Shares Change (YoY)	-2.09%
Shares Change (QoQ)	+12.74%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	16.68%
Float	2.08B

Valuation Ratios

The trailing PE ratio is 12.22 and the forward PE ratio is 12.29.

PE Ratio	12.22
Forward PE	12.29
PS Ratio	0.17
PB Ratio	1.07
P/TBV Ratio	1.12
P/FCF Ratio	76.95
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.28, with an EV/FCF ratio of 96.62.

EV / Earnings	14.95
EV / Sales	0.21
EV / EBITDA	6.28
EV / EBIT	7.40
EV / FCF	96.62

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.44.

Current Ratio	1.27
Quick Ratio	0.91
Debt / Equity	0.44
Debt / EBITDA	2.94
Debt / FCF	45.21
Interest Coverage	3.26

Financial Efficiency

Return on equity (ROE) is 7.15% and return on invested capital (ROIC) is 5.63%.

Return on Equity (ROE)	7.15%
Return on Assets (ROA)	2.66%
Return on Capital (ROIC)	5.63%
Revenue Per Employee	4.96M
Profits Per Employee	67,992
Employee Count	30,100
Asset Turnover	1.54
Inventory Turnover	8.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.93% in the last 52 weeks. The beta is 0.16, so Jointown Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-9.93%
50-Day Moving Average	5.35
200-Day Moving Average	5.37
Relative Strength Index (RSI)	29.31
Average Volume (20 Days)	27,434,693

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jointown Pharmaceutical Group had revenue of CNY 149.20 billion and earned 2.05 billion in profits. Earnings per share was 0.41.

Revenue	149.20B
Gross Profit	11.75B
Operating Income	4.14B
Pretax Income	2.90B
Net Income	2.05B
EBITDA	4.78B
EBIT	4.14B
Earnings Per Share (EPS)	0.41

Full Income Statement

Balance Sheet

The company has 16.24 billion in cash and 14.31 billion in debt, giving a net cash position of 1.93 billion or 0.39 per share.

Cash & Cash Equivalents	16.24B
Total Debt	14.31B
Net Cash	1.93B
Net Cash Per Share	0.39
Equity (Book Value)	32.81B
Book Value Per Share	4.65
Working Capital	17.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.29 billion and capital expenditures -974.29 million, giving a free cash flow of 316.59 million.

Operating Cash Flow	1.29B
Capital Expenditures	-974.29M
Free Cash Flow	316.59M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 7.88%, with operating and profit margins of 2.77% and 1.37%.

Gross Margin	7.88%
Operating Margin	2.77%
Pretax Margin	1.95%
Profit Margin	1.37%
EBITDA Margin	3.20%
EBIT Margin	2.77%
FCF Margin	0.21%

Dividends & Yields

This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 3.91%.

Dividend Per Share	0.19
Dividend Yield	3.91%
Dividend Growth (YoY)	-9.70%
Years of Dividend Growth	n/a
Payout Ratio	77.98%
Buyback Yield	2.09%
Shareholder Yield	5.99%
Earnings Yield	8.19%
FCF Yield	1.30%

Dividend Details

Stock Splits

The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.29.

Last Split Date	Jun 7, 2024
Split Type	Forward
Split Ratio	1.29

Scores

Jointown Pharmaceutical Group has an Altman Z-Score of 2.26. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	n/a